Hepbest 25 mg Tablet

Hepbest 25 mg Tablet is an antiviral medication. Doctors primarily recommend it to treat chronic hepatitis B virus infection and HIV-1 infection.

Description

Uses of Hepbest 25 mg Tablet

Hepbest 25 mg Tablet is used for the treatment of HIV infection and chronic hepatitis B infection. The medicine has a composition of Tenofovir Alafenamide. It stops the multiplication of viruses in human cells.

Dosage of Hepbest 25 mg Tablet

  • Take the medicine as per the dosage prescribed by your doctor.
  • Avoid skipping any dosage and finish the treatment even if you feel better.
  • Your doctor will decide whether to take it with or without food.
  • Do not stop the medicine without asking your doctor.

Precautions and Warnings

  • Some common side effects of the medicine are headache, diarrhea, nausea, indigestion, etc. Consult your doctor if the side effects last long.
  • Patients rarely experience skin reactions or liver damage. So, your doctor will check on you for these at the beginning of the treatment.
  • Inform your doctor if you have skin issues and liver or kidney issues.
  • Perform regular blood tests to check your blood count and liver function.
  • Do not drink alcohol as it may lead to liver damage.
  • Pregnant women or breastfeeding mothers must consult their doctors before taking the medicine.
  • Take precautions during sexual intercourse. Avoid sharing your personal items if you are HIV positive.

Why choose SDO for medicine supply and export?

SDO Phamed is one of the largest manufacturer and supplier of Hepbest 25 mg Tablets. It is a reputed UAE-based medicine supply and export company. SDO also manufactures and exports cancer medicines, vaccines, and general pharma medicines. The company exports best quality medicines to overseas countries like Saudi Arabia, Yemen, Kazakhstan, Oman, Russia, and most European countries. We deliver premium-grade medicines on time.

Reviews

There are no reviews yet.

Be the first to review “Hepbest 25 mg Tablet”

Your email address will not be published. Required fields are marked *